NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	Nippon India Pharma Fund - Direct (G)
Fund Type	Equity
Risk	Very High
Min SIP Amount	₹100
Min Lumpsum	₹5,000
Expense Ratio	0.99%
NAV	₹663.12 (11 Nov 2026)
Fund Size	₹9,087.25 Cr
Fund Started	02 Jan 2013
Lock-in Period	No lock-in
Exit Load	1%If redeemed or switched out on or before completion of 1 Months from the date of allotment of units NilIf redeemed or switched out after the completion of 1 Months from the date of allotment of units

Returns	Nippon India Pharma Fund - Direct (G)
1M	8.35%
3M	3.22%
6M	9.83%
1Y	16.10%
3Y	18.86%
5Y	15.30%
Since Inception	17.62%

Trailing risk-adjusted performance measures

Risk Ratio	Nippon India Pharma Fund - Direct (G)
Alpha	12.37
Beta	0.65
Sharpe	0.84
Standard Deviation	4.29

Holding Analysis	Nippon India Pharma Fund - Direct (G)
Top 5 Holdings	36.78%
Top 10 Holdings	57.16%
Portfolio Turnover	0.15
Equity	99.62%
Debt	0.52%
Cash	—

Name	Assets
Sun Pharmaceutical ...Equity	11.55%
Divis Laboratories LtdEquity	6.73%
Cipla LtdEquity	6.21%
Lupin LtdEquity	6.16%
Dr Reddys Laborator...Equity	6.13%
Apollo Hospitals En...Equity	5.10%
Mankind Pharma LtdEquity	4.40%
Sai Life Sciences LtdEquity	4.04%
Ajanta Pharma LtdEquity	3.53%
Max Healthcare Inst...Equity	3.31%

Fund Manager	Nippon India Pharma Fund - Direct (G)
Name	, , , ,

About	Nippon India Pharma Fund - Direct (G)
AMC	Nippon India Mutual Fund
Scheme Category	Sectoral Fund
Benchmark	BSE Healthcare TRI
Launch Date	01 Jan 2013